Clinical Trials Directory

Trials / Completed

CompletedNCT06326866

Otoacoustic Emissions in Different Blood Types

The Association of Blood Type Differences and Signal-Noise Ratio in TEOAE and DPAOE in Individuals With Normal Hearing

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Istanbul University - Cerrahpasa · Academic / Other
Sex
All
Age
18 Years – 26 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to examine whether ABO and Rhesus (Rh) blood group systems have an association with distortion product otoacoustic emission (DPOAE) and transient otoacoustic emission (TEOAE) amplitudes with the hypothesis of blood groups may affect hearing thresholds.

Detailed description

Many factors have a significant impact on otoacoustic emission (OAE) measurement and quality of analysis. Race, age and gender are among the non-pathological factors. To date there is clear data to demonstrate the association of blood types with OAEs. The aim of our research is to investigate the relation of different blood groups (ABO) and Rh factors on transient evoked OAE and distortion product OAE amplitudes and inner ear potentials, differences between ears and to contribute to the limited literature on cochlear hearing loss susceptibility and blood groups with the hypothesis that blood groups may be associated with hearing thresholds.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOtoacoustic emissions (non-invasive)There is no invasive intervention in the study. Individuals with predetermined blood types will be included in the study.

Timeline

Start date
2024-02-07
Primary completion
2024-03-12
Completion
2024-03-18
First posted
2024-03-22
Last updated
2024-03-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06326866. Inclusion in this directory is not an endorsement.